Mylotarg Now Approved Pages Sep 18, 2017 Brand: Mylotarg (gemtuzumab ozogamicin), Intravenous Infusion Parent Company: Pfizer Drug Type: Boxed Warning Drug Category: Oncology Campaign: now-approved Targeting: HCPs, Patients Patient Website: https://www.mylotarg.com/ HCP Website: https://www.mylotarghcp.com/ Patient Homepage HCP Homepage Patient Homepage – Mobile HCP Homepage – Mobile